Insights

NZX revenue growth comparison

Revenue growth rates across covered NZX companies, ranked by each company's latest reported period.

Last updated 3 June 2026

Revenue growth trend

Reported revenue growth across covered companies; base-effect moves above 500% are omitted from the chart.

Loading chart...

FY21 AFC: Outside range low revenue growth. -47.6%; 4-period range -44% to 159%. Revenue growth: -47.6%, below normal range; 4-period mean 25.6%, range -44.0%-159.0%.
FY23 AFC: Unprecedented high revenue growth. 159%; 4-period range -47.6% to 23.2%. Revenue growth: 159.0%, unprecedented high; 4-period mean -26.1%, range -47.6%-23.2%.
HY23 AIR: Outside range high revenue growth. 173.6%; 3-period range -2% to 11.2%. Revenue growth: 173.6%, above normal range; 3-period mean 3.5%, range -2.0%-11.2%.
FY23 AIR: Outside range high revenue growth. 131.5%; 3-period range 0% to 8.6%. Revenue growth: 131.5%, above normal range; 3-period mean 5.1%, range 0.0%-8.6%.
HY25 AIR: Outside range low revenue growth. -2%; 3-period range 1.2% to 173.6%. Revenue growth: -2.0%, below normal range; 3-period mean 62.0%, range 1.2%-173.6%.
FY25 AIR: Outside range low revenue growth. 0%; 3-period range 6.7% to 131.5%. Revenue growth: 0.0%, below normal range; 3-period mean 48.9%, range 6.7%-131.5%.
FY20 AOF: Outside range low revenue growth. -40.2%; 3-period range 5% to 74.1%. Revenue growth: -40.2%, below normal range; 3-period mean 31.6%, range 5.0%-74.1%.
FY21 AOF: Outside range high revenue growth. 74.1%; 3-period range -40.2% to 15.7%. Revenue growth: 74.1%, above normal range; 3-period mean -6.5%, range -40.2%-15.7%.
HY22 ARB: Outside range low revenue growth. -61.3%; 3-period range 7.6% to 78.4%. Revenue growth: -61.3%, below normal range; 3-period mean 49.0%, range 7.6%-78.4%.
HY24 ARB: Outside range high revenue growth. 78.4%; 3-period range -61.3% to 60.9%. Revenue growth: 78.4%, above normal range; 3-period mean 2.4%, range -61.3%-60.9%.
FY21 ARG: Outside range high revenue growth. 6.9%; 5-period range -50.7% to 3.3%. Revenue growth: 6.9%, above normal range; 5-period mean -26.8%, range -50.7%-3.3%.
FY22 ARG: Outside range low revenue growth. -50.7%; 5-period range -49.9% to 6.9%. Revenue growth: -50.7%, below normal range; 5-period mean -15.3%, range -49.9%-6.9%.
FY23 APL: Unprecedented low revenue growth. -46.6%; 4-period range -16.4% to 27.9%. Revenue growth: -46.6%, unprecedented low; 4-period mean -1.6%, range -16.4%-27.9%.
HY24 APL: Outside range low revenue growth. -39.7%; 3-period range -33.4% to 24%. Revenue growth: -39.7%, below normal range; 3-period mean -3.5%, range -33.4%-24.0%.
HY25 APL: Outside range high revenue growth. 24%; 3-period range -39.7% to -1.2%. Revenue growth: 24.0%, above normal range; 3-period mean -24.7%, range -39.7%--1.2%.
FY25 APL: Unprecedented high revenue growth. 27.9%; 4-period range -46.6% to -3.8%. Revenue growth: 27.9%, unprecedented high; 4-period mean -20.2%, range -46.6%--3.8%.
FY21 AIA: Unprecedented low revenue growth. -50.4%; 4-period range 6.8% to 108.4%. Revenue growth: -50.4%, unprecedented low; 4-period mean 42.6%, range 6.8%-108.4%.
HY22 AIA: Outside range low revenue growth. -4%; 4-period range 3.9% to 128.1%. Revenue growth: -4.0%, below normal range; 4-period mean 49.7%, range 3.9%-128.1%.
HY23 AIA: Unprecedented high revenue growth. 128.1%; 4-period range -4% to 53.1%. Revenue growth: 128.1%, unprecedented high; 4-period mean 16.6%, range -4.0%-53.1%.
FY23 AIA: Unprecedented high revenue growth. 108.4%; 4-period range -50.4% to 43.1%. Revenue growth: 108.4%, unprecedented high; 4-period mean 2.9%, range -50.4%-43.1%.
HY22 AFI: Unprecedented high revenue growth. 68.1%; 4-period range -5.4% to 10.1%. Revenue growth: 68.1%, unprecedented high; 4-period mean 1.2%, range -5.4%-10.1%.
FY23 AFI: Outside range low revenue growth. -8.5%; 3-period range -1.2% to 53.4%. Revenue growth: -8.5%, below normal range; 3-period mean 18.0%, range -1.2%-53.4%.
HY24 AFI: Outside range low revenue growth. -5.4%; 4-period range -2.8% to 68.1%. Revenue growth: -5.4%, below normal range; 4-period mean 19.6%, range -2.8%-68.1%.
HY23 BLT: Outside range low revenue growth. 10.2%; 3-period range 11.4% to 28.1%. Revenue growth: 10.2%, below normal range; 3-period mean 21.6%, range 11.4%-28.1%.
FY25 BLT: Outside range low revenue growth. 9.7%; 3-period range 12.6% to 16%. Revenue growth: 9.7%, below normal range; 3-period mean 14.3%, range 12.6%-16.0%.
HY26 BLT: Outside range high revenue growth. 28.1%; 3-period range 10.2% to 25.4%. Revenue growth: 28.1%, above normal range; 3-period mean 15.7%, range 10.2%-25.4%.
FY26 BLT: Outside range high revenue growth. 16%; 3-period range 9.7% to 14.2%. Revenue growth: 16.0%, above normal range; 3-period mean 12.2%, range 9.7%-14.2%.
FY25 BRW: Outside range high revenue growth. 10.7%; 4-period range -49.7% to -3.2%. Revenue growth: 10.7%, above normal range; 4-period mean -19.4%, range -49.7%--3.2%.
FY26 BRW: Unprecedented low revenue growth. -49.7%; 4-period range -14.4% to 10.7%. Revenue growth: -49.7%, unprecedented low; 4-period mean -4.3%, range -14.4%-10.7%.
HY22 BGP: Outside range high revenue growth. 22.6%; 3-period range 0% to 2.7%. Revenue growth: 22.6%, above normal range; 3-period mean 1.3%, range 0.0%-2.7%.
FY22 BGP: Outside range high revenue growth. 6.1%; 4-period range -0.1% to 5.6%. Revenue growth: 6.1%, above normal range; 4-period mean 1.8%, range -0.1%-5.6%.
FY25 BGP: Outside range low revenue growth. -0.1%; 4-period range 0.8% to 6.1%. Revenue growth: -0.1%, below normal range; 4-period mean 3.3%, range 0.8%-6.1%.
HY26 BGP: Outside range low revenue growth. 0%; 3-period range 1.1% to 22.6%. Revenue growth: 0.0%, below normal range; 3-period mean 8.8%, range 1.1%-22.6%.
HY22 BFG: Outside range high revenue growth. 16%; 4-period range -1.3% to 15.9%. Revenue growth: 16.0%, above normal range; 4-period mean 6.9%, range -1.3%-15.9%.
FY23 BFG: Outside range high revenue growth. 24.8%; 3-period range -8.4% to 13.6%. Revenue growth: 24.8%, above normal range; 3-period mean 4.2%, range -8.4%-13.6%.
HY25 BFG: Outside range low revenue growth. -1.3%; 4-period range -0.6% to 16%. Revenue growth: -1.3%, below normal range; 4-period mean 11.3%, range -0.6%-16.0%.
FY25 BFG: Outside range low revenue growth. -8.4%; 3-period range 7.4% to 24.8%. Revenue growth: -8.4%, below normal range; 3-period mean 15.3%, range 7.4%-24.8%.
HY23 CDI: Outside range low revenue growth. -75.1%; 3-period range -22.2% to 40.3%. Revenue growth: -75.1%, below normal range; 3-period mean 0.3%, range -22.2%-40.3%.
FY23 CDI: Outside range low revenue growth. -54.1%; 4-period range -27% to 59.4%. Revenue growth: -54.1%, below normal range; 4-period mean 3.4%, range -27.0%-59.4%.
HY24 CDI: Outside range high revenue growth. 40.3%; 3-period range -75.1% to -17.2%. Revenue growth: 40.3%, above normal range; 3-period mean -38.2%, range -75.1%--17.2%.
FY24 CDI: Unprecedented high revenue growth. 59.4%; 4-period range -54.1% to 3.7%. Revenue growth: 59.4%, unprecedented high; 4-period mean -24.9%, range -54.1%-3.7%.
FY22 CHI: Unprecedented low revenue growth. -61.9%; 4-period range -0.9% to 48.1%. Revenue growth: -61.9%, unprecedented low; 4-period mean 13.6%, range -0.9%-48.1%.
HY23 CHI: Outside range high revenue growth. 115.9%; 3-period range -74.1% to 8.4%. Revenue growth: 115.9%, above normal range; 3-period mean -21.7%, range -74.1%-8.4%.
FY23 CHI: Unprecedented high revenue growth. 48.1%; 4-period range -61.9% to 7%. Revenue growth: 48.1%, unprecedented high; 4-period mean -13.9%, range -61.9%-7.0%.
HY23 CNU: Outside range low revenue growth. 0.8%; 3-period range 1.2% to 141.8%. Revenue growth: 0.8%, below normal range; 3-period mean 49.0%, range 1.2%-141.8%.
HY24 CNU: Outside range high revenue growth. 141.8%; 3-period range 0.8% to 4%. Revenue growth: 141.8%, above normal range; 3-period mean 2.0%, range 0.8%-4.0%.
HY23 CEN: Outside range low revenue growth. -12.7%; 3-period range -5.3% to 31.4%. Revenue growth: -12.7%, below normal range; 3-period mean 18.9%, range -5.3%-31.4%.
HY24 CEN: Outside range high revenue growth. 31.4%; 3-period range -12.7% to 30.7%. Revenue growth: 31.4%, above normal range; 3-period mean 4.2%, range -12.7%-30.7%.
FY22 CCC: Outside range high revenue growth. 283.3%; 3-period range -29.4% to 83.7%. Revenue growth: 283.3%, above normal range; 3-period mean 18.3%, range -29.4%-83.7%.
FY24 CCC: Outside range low revenue growth. -29.4%; 3-period range 0.7% to 283.3%. Revenue growth: -29.4%, below normal range; 3-period mean 122.6%, range 0.7%-283.3%.
FY23 ERD: Outside range high revenue growth. 52.2%; 3-period range 0.4% to 6.8%. Revenue growth: 52.2%, above normal range; 3-period mean 3.8%, range 0.4%-6.8%.
FY26 ERD: Outside range low revenue growth. 0.4%; 3-period range 4.1% to 52.2%. Revenue growth: 0.4%, below normal range; 3-period mean 21.0%, range 4.1%-52.2%.
HY23 FPH: Outside range low revenue growth. -23.3%; 3-period range 14.4% to 18.4%. Revenue growth: -23.3%, below normal range; 3-period mean 16.4%, range 14.4%-18.4%.
HY25 FPH: Outside range high revenue growth. 18.4%; 3-period range -23.3% to 16.4%. Revenue growth: 18.4%, above normal range; 3-period mean 2.5%, range -23.3%-16.4%.
FY21 FBU: Unprecedented high revenue growth. 11.1%; 4-period range -9.3% to 4.7%. Revenue growth: 11.1%, unprecedented high; 4-period mean -3.5%, range -9.3%-4.7%.
HY23 FBU: Outside range high revenue growth. 5.4%; 4-period range -20% to 1.9%. Revenue growth: 5.4%, above normal range; 4-period mean -8.6%, range -20.0%-1.9%.
FY24 FBU: Outside range low revenue growth. -9.3%; 4-period range -9% to 11.1%. Revenue growth: -9.3%, below normal range; 4-period mean 1.6%, range -9.0%-11.1%.
HY26 FBU: Unprecedented low revenue growth. -20%; 4-period range -15.7% to 5.4%. Revenue growth: -20.0%, unprecedented low; 4-period mean -2.3%, range -15.7%-5.4%.
HY23 GEN: Outside range high revenue growth. 94.7%; 3-period range 19% to 38.7%. Revenue growth: 94.7%, above normal range; 3-period mean 29.1%, range 19.0%-38.7%.
HY26 GEN: Outside range low revenue growth. 19%; 3-period range 29.7% to 94.7%. Revenue growth: 19.0%, below normal range; 3-period mean 54.3%, range 29.7%-94.7%.
HY23 GNE: Outside range low revenue growth. -16.4%; 3-period range -12.9% to 28.9%. Revenue growth: -16.4%, below normal range; 3-period mean 11.4%, range -12.9%-28.9%.
HY25 GNE: Outside range high revenue growth. 28.9%; 3-period range -16.4% to 18.3%. Revenue growth: 28.9%, above normal range; 3-period mean -3.7%, range -16.4%-18.3%.
HY23 GXH: Outside range high revenue growth. 14.6%; 3-period range -29.5% to 3.9%. Revenue growth: 14.6%, above normal range; 3-period mean -7.9%, range -29.5%-3.9%.
HY24 GXH: Outside range low revenue growth. -29.5%; 3-period range 1.8% to 14.6%. Revenue growth: -29.5%, below normal range; 3-period mean 6.8%, range 1.8%-14.6%.
FY21 HLG: Unprecedented high revenue growth. 21.9%; 4-period range 0.1% to 16.7%. Revenue growth: 21.9%, unprecedented high; 4-period mean 7.8%, range 0.1%-16.7%.
HY22 HLG: Outside range low revenue growth. -6.2%; 4-period range -0.2% to 30.9%. Revenue growth: -6.2%, below normal range; 4-period mean 13.3%, range -0.2%-30.9%.
FY22 HLG: Unprecedented low revenue growth. 0.1%; 4-period range 6.3% to 21.9%. Revenue growth: 0.1%, unprecedented low; 4-period mean 13.3%, range 6.3%-21.9%.
HY23 HLG: Unprecedented high revenue growth. 30.9%; 4-period range -6.2% to 14.7%. Revenue growth: 30.9%, unprecedented high; 4-period mean 4.0%, range -6.2%-14.7%.
FY22 HGH: Outside range high revenue growth. 11.7%; 3-period range 0.2% to 11.1%. Revenue growth: 11.7%, above normal range; 3-period mean 4.9%, range 0.2%-11.1%.
HY24 HGH: Unprecedented low revenue growth. -2%; 4-period range 8.9% to 11.1%. Revenue growth: -2.0%, unprecedented low; 4-period mean 10.0%, range 8.9%-11.1%.
FY24 HGH: Outside range low revenue growth. 0.2%; 3-period range 3.3% to 11.7%. Revenue growth: 0.2%, below normal range; 3-period mean 8.7%, range 3.3%-11.7%.
HY26 HGH: Outside range high revenue growth. 11.1%; 4-period range -2% to 10.2%. Revenue growth: 11.1%, above normal range; 4-period mean 6.8%, range -2.0%-10.2%.

← Swipe to view more

NZX revenue growth comparison table
Company	Ticker	Period	Period type	Revenue	Revenue growth	Prior growth
Henderson Far East Income	HFL	HY26	6 months	$23.1m	208.4%	-3.1%
Cooks Coffee Company	CCC	FY26	12 months	$12.4m	83.7%	-29.4%
Scales Corporation	SCL	FY25	12 months	$899.9m	53.9%Unprecedented high revenue growth. 53.9%; 4-period range -8.7% to 20.3%. Revenue growth: 53.9%, unprecedented high; 4-period mean 6.1%, range -8.7%-20.3%.	16.9%
Truscreen Group	TRU	FY26	12 months	$2.4m	42.2%Caveat: insufficient history.	-0.7%
Serko	SKO	FY26	12 months	$119.4m	34.9%	47.4%
Rakon	RAK	HY26	6 months	$54.2m	30.2%Outside range high revenue growth. 30.2%; 3-period range -32% to 2%. Revenue growth: 30.2%, above normal range; 3-period mean -19.9%, range -32.0%-2.0%.	-32.0%
Promisia Healthcare	PHL	FY26	12 months	$40.1m	29.1%	25.6%
General Capital	GEN	HY26	6 months	$12.9m	19.0%Outside range low revenue growth. 19%; 3-period range 29.7% to 94.7%. Revenue growth: 19.0%, below normal range; 3-period mean 54.3%, range 29.7%-94.7%.	31.8%
Comvita	CVT	HY26	6 months	$118m	18.3%Caveat: insufficient history.	-7.8%
Third Age Health Services	TAH	FY26	12 months	$22.5m	17.9%Caveat: insufficient history.	94.4%
South Port New Zealand	SPN	HY26	6 months	$34.8m	17.5%Outside range high revenue growth. 17.5%; 4-period range -0.2% to 16.1%. Revenue growth: 17.5%, above normal range; 4-period mean 6.2%, range -0.2%-16.1%.	12.7%
BLIS Technologies	BLT	FY26	12 months	$14.7m	16.0%Outside range high revenue growth. 16%; 3-period range 9.7% to 14.2%. Revenue growth: 16.0%, above normal range; 3-period mean 12.2%, range 9.7%-14.2%.	28.1%
AoFrio	AOF	FY22	12 months	$74.3m	15.7%	74.1%
Hallenstein Glasson	HLG	HY26	6 months	$275.2m	14.7%	8.1%
T&G Global Limited and subsidiary companies	TGG	FY25	12 months	$1.6b	14.5%Unprecedented high revenue growth. 14.5%; 4-period range -4.4% to 2.3%. Revenue growth: 14.5%, unprecedented high; 4-period mean -0.8%, range -4.4%-2.3%.	12.3%
Fisher & Paykel Healthcare	FPH	FY26	12 months	$2.3b	14.2%Caveat: insufficient history.	14.4%
Radius Residential Care	RAD	FY26	12 months	$200.1m	14.2%	19.0%
Enprise Group	ENS	FY25	12 months	$24.8m	13.6%Caveat: insufficient history.	21.2%
Summerset Group Holdings	SUM	FY25	12 months	$361.8m	13.1%Outside range low revenue growth. 13.1%; 3-period range 14% to 17.5%. Revenue growth: 13.1%, below normal range; 3-period mean 15.9%, range 14.0%-17.5%.	14.1%
EBOS Group	EBO	HY26	6 months	$6.8b	13.0%Caveat: insufficient history.	-7.0%
Ryman Healthcare	RYM	FY26	12 months	$855.6m	12.5%Caveat: insufficient history.	13.0%
The a2 Milk Company	ATM	HY26	6 months	$992.6m	11.2%Caveat: insufficient history.	13.5%
Heartland Group Holdings	HGH	HY26	6 months	$172.3m	11.1%Outside range high revenue growth. 11.1%; 4-period range -2% to 10.2%. Revenue growth: 11.1%, above normal range; 4-period mean 6.8%, range -2.0%-10.2%.	11.1%
Skellerup Holdings	SKL	HY26	6 months	$183.5m	11.0%Caveat: insufficient history.	6.9%
Goodman Property Trust	GMT	HY26	6 months	$148.8m	10.4%Caveat: basis discontinuity, transaction distorted.	—
Goodman Property Trust	GNZ	HY26	6 months	$148.8m	10.4%Caveat: insufficient history.	13.8%
Vista Group International	VGL	FY25	12 months	$164.3m	9.5%Caveat: insufficient history.	10.6%
Turners Automotive Group	TRA	FY26	12 months	$450.2m	9.0%	7.0%
The Colonial Motor Company	CMO	HY26	6 months	$552.4m	8.8%	-1.1%
Napier Port Holdings	NPH	HY26	6 months	$84.9m	8.7%	11.6%
PGG Wrightson	PGW	HY26	6 months	$619.4m	8.6%Caveat: insufficient history.	6.5%
Port of Tauranga	POT	HY26	6 months	$244.1m	8.5%	—
Freightways Group	FRW	HY26	6 months	$718.2m	8.5%Caveat: insufficient history.	6.6%
Steel & Tube Holdings	STU	HY26	6 months	$211.9m	8.1%Caveat: insufficient history.	-19.6%
ArborGen Holdings	ARB	FY26	12 months	$68.2m	7.9%	7.6%
Sky Network Television	SKT	HY26	6 months	$414.4m	7.7%Unprecedented high revenue growth. 7.7%; 4-period range -2% to 4.1%. Revenue growth: 7.7%, unprecedented high; 4-period mean 1.9%, range -2.0%-4.1%.	-2.1%
Burger Fuel Group	BFG	FY26	12 months	$25.6m	7.4%	-0.6%
KMD Brands	KMD	HY26	6 months	$505.4m	7.3%Caveat: insufficient history.	1.0%
Seeka	SEK	FY25	12 months	$439.6m	6.9%Outside range low revenue growth. 6.9%; 3-period range 12.5% to 41.5%. Revenue growth: 6.9%, below normal range; 3-period mean 30.2%, range 12.5%-41.5%.	36.7%
New Zealand King Salmon Investments	NZK	HY26	6 months	$100.3m	6.1%	-7.1%
Vector	VCT	HY26	6 months	$594.4m	6.1%	-3.3%
Millennium & Copthorne Hotels New Zealand	MCK	FY25	12 months	$186.7m	6.0%	-7.1%
ikeGPS Group	IKE	FY26	12 months	$26.5m	5.5%	5.6%
Scott Technology	SCT	HY26	6 months	$128.2m	5.3%	-0.3%
Livestock Improvement Corporation	LIC	HY26	6 months	$195.2m	5.2%Caveat: insufficient history.	10.4%
My Food Bag Group	MFB	FY26	12 months	$170.2m	5.0%Outside range high revenue growth. 5%; 4-period range -9.4% to 1.7%. Revenue growth: 5.0%, above normal range; 4-period mean -2.0%, range -9.4%-1.7%.	3.8%
Westpac Banking Corporation	WBC	HY26	6 months	$11.3m	4.6%	—
Green Cross Health	GXH	FY26	12 months	$546m	4.2%Caveat: insufficient history.	1.8%
Tourism Holdings	THL	HY26	6 months	$477.3m	4.1%Caveat: insufficient history.	-7.0%
Auckland International Airport	AIA	HY26	6 months	$519.6m	3.9%	12.2%
Arvida Group	ARV	FY26	12 months	$262.7m	3.6%	5.1%
Argosy Property	ARG	FY26	12 months	$120.8m	3.3%	-49.9%
Michael Hill International	MHJ	HY26	6 months	$371m	3.0%	2.5%
Kiwi Property Group	KPG	FY26	12 months	$271.4m	2.9%	6.5%
Mainfreight	MFT	FY26	12 months	$5.4b	2.8%	11.0%
Restaurant Brands New Zealand	RBD	HY25	6 months	$743.3m	2.5%Caveat: basis discontinuity.	—
Barramundi	BRM	HY26	6 months	$2.4m	2.2%	16.2%
Air New Zealand	AIR	HY26	6 months	$3.4b	1.2%	0.0%
Chorus	CNU	HY26	6 months	$506m	1.2%	0.4%
Briscoe Group	BGP	FY26	12 months	$798.8m	0.9%	0.0%
Precinct Properties	PCT	HY26	6 months	$135.4m	0.7%	7.3%
Delegat Group	DGL	HY26	6 months	$179.6m	0.5%Caveat: insufficient history.	-12.0%
EROAD	ERD	FY26	12 months	$195.2m	0.4%Outside range low revenue growth. 0.4%; 3-period range 4.1% to 52.2%. Revenue growth: 0.4%, below normal range; 3-period mean 21.0%, range 4.1%-52.2%.	3.3%
Channel Infrastructure NZ	CHI	FY25	12 months	$140.2m	0.3%	0.5%
Vulcan Steel	VSL	HY25	6 months	$493m	0.0%	—
Oceania Healthcare	OCA	HY26	6 months	$131.6m	-0.7%	-1.8%
GEO	GEO	FY23	12 months	$3.1m	-1.2%Caveat: restatement or reclassification.	—
NZME	NZM	FY25	12 months	$341.3m	-1.3%Caveat: insufficient history.	-2.8%
Tower	TWR	HY26	6 months	$291.2m	-1.6%	6.9%
Gentrack Group Limited 6 months to 31 March 2026	GTK	HY26	6 months	$110.1m	-1.7%Caveat: insufficient history.	8.0%
Spark New Zealand	SPK	HY26	6 months	$1.9m	-2.4%	-3.5%
Savor	SVR	FY26	12 months	$55.2m	-2.6%	-8.4%
Metro Performance Glass	MPG	FY26	12 months	$208.2m	-2.7%	-5.3%
Australian Foundation Investment Company	AFI	HY26	6 months	$168.7m	-2.8%	3.0%
SkyCity Entertainment Group	SKC	HY26	6 months	$406.5m	-3.4%Caveat: insufficient history.	-4.6%
Asset Plus	APL	FY26	12 months	$6.6m	-3.8%	-1.2%
MOVE Logistics Group	MOV	HY26	6 months	$141.4m	-4.7%Caveat: insufficient history.	-2.6%
Mercury NZ	MCY	HY26	6 months	$1.7b	-5.2%	2.2%
Contact Energy	CEN	HY26	6 months	$1.6b	-5.3%	20.1%
Sanford	SAN	HY26	6 months	$270.2m	-5.5%	0.2%
Meridian Energy	MEL	HY26	6 months	$2b	-11.0%Outside range low revenue growth. -11%; 3-period range -8.6% to 38.1%. Revenue growth: -11.0%, below normal range; 3-period mean 12.1%, range -8.6%-38.1%.	-0.4%
Genesis Energy	GNE	HY26	6 months	$1.5b	-12.9%	20.2%
Infratil	IFT	HY26	6 months	$1.5b	-14.4%Outside range low revenue growth. -14.4%; 4-period range -6.4% to 112.9%. Revenue growth: -14.4%, below normal range; 4-period mean 37.9%, range -6.4%-112.9%.	11.7%
Synlait Milk	SML	HY26	6 months	$777.6m	-15.2%	40.4%
Marlin Global	MLN	HY26	6 months	$9.4m	-17.2%	1.9%
Templeton Emerging Markets Investment Trust Plc	TEM	HY24	6 months	$45.5m	-19.6%	75.0%
Fletcher Building	FBU	HY26	6 months	$2.9b	-20.0%Unprecedented low revenue growth. -20%; 4-period range -15.7% to 5.4%. Revenue growth: -20.0%, unprecedented low; 4-period mean -2.3%, range -15.7%-5.4%.	-9.0%
CDL Investments New Zealand	CDI	FY25	12 months	$38.1m	-22.3%	-17.2%
Me Today	MEE	HY26	6 months	$2.6m	-31.7%	48.1%
AFC Group Holdings	AFC	FY25	12 months	$0.74m	-44.0%	-17.8%
Pacific Edge	PEB	HY26	6 months	$5.9m	-45.8%Caveat: insufficient history.	-8.6%
The Warehouse Group	WHS	FY25	12 months	$1.6b	-47.1%Caveat: insufficient history.	-10.6%
Bremworth	BRW	FY26	12 months	$44.7m	-49.7%Unprecedented low revenue growth. -49.7%; 4-period range -14.4% to 10.7%. Revenue growth: -49.7%, unprecedented low; 4-period mean -4.3%, range -14.4%-10.7%.	10.7%
Winton Land	WIN	HY26	6 months	$32.4m	-60.0%Caveat: insufficient history.	-10.4%
Being AI	BAI	HY24	6 months	$0m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	—
Blackwell Global Holdings	RTO	HY26	6 months	$0.07m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.
Fonterra Co-operative Group	FCG	HY26	6 months	$167m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.
Iperion	IPR	FY26	12 months	$0m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	—
Kingfish	KFL	FY26	12 months	-$8.3m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	262.8%
New Talisman Gold Mines	NTL	HY26	6 months	$4.8m	—	-44.2%
New Zealand Rural Land Company	NZL	HY22	6 months	$4.3m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	—
Property for Industry	PFI	HY26	6 months	$73.6m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	170.1%
Rua Bioscience	RUA	HY26	6 months	$1.3m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	490.6%

Source: latest published result per company in the current Annolyse coverage set.

NZX revenue growth comparison table

Copy, export, or share this public Annolyse data reference.

Revenue growth is the simplest comparison, but it still needs period context. Half-year results are not directly comparable with full-year absolute revenue, so the useful signal is the growth rate and whether the company is growing from volume, price, acquisitions, or recovery from a weak base.

Related insights

NZX cash conversion comparison

Operating cash flow versus EBITDA across the Annolyse coverage set, using each company's most recent published result.

NZX dividend coverage comparison

Payout ratios against NPAT and free cash flow for the latest published result from each covered company.

NZX leverage comparison

Net debt and net debt / EBITDA across the Annolyse coverage set, ranked by the latest reported leverage position.

NZX earnings quality comparison

PBT versus NPAT divergence across covered NZX companies, highlighting tax, fair-value, and non-operating distortions.

NZX ROE comparison

Return on equity across covered NZX companies, with prior-period movement and leverage context.

NZX working capital comparison

Debtor days and inventory days across covered NZX companies, showing where cash is tied up in receivables or stock.

Get updates to NZX revenue growth comparison

Get the next relevant NZX result briefings and refreshed comparison views by email.